Novartis announces a gender-neutral parental leave policy
MUMBAI: MNC drug Novartis announced a neutral gender Parental policy for its employees through its entities in India. The new parental leave policy , effective as of July 1, applies to childbirth and parents who are not born in the case of birth, adoption And subrogation, says a statement from the company.
The policy is applicable with retrospective effect to employees who became parents on or after January 30, 2019. In both parents work with Novartis, both will be entitled to 26 weeks leave.
“People are key to the success of an organization and we believe that by recognizing moments that matter in the lives of our associates, we will contribute to better work-life balance. Our parental leave policy is a symbol of equality for all new parents in the company, offering choice and giving both parents precious time to spend bonding with their new baby. Becoming a parent is a life-changing event and we want our people to cherish the experience. We believe that this move will enrich the workplace and foster a more inclusive culture in the organization,” says Sanjay Murdeshwar country president, Novartis India .Non-birthing parents will have the flexibility of taking leave in one go or two tranches of 13 weeks each within a year of birth/ adoption /surrogacy of their new child. The first employees to avail this opportunity are expected to resume work in January 2020. Novartis will offer coaching to associates going on leave for a seamless reintegration into the workplace when they resume work. There is no cap on the number of births and in case of premature birth, depending on the number of weeks of prematurity, employees will be entitled to additional parental leave.